BlackRock, Inc. (BLK) 13D/13G Filings for Harvard Bioscience, Inc. (HBIO)

BlackRock, Inc. 13D and 13G filings for Harvard Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-26
5:26 pm
Purchase		 2023-12-31 13G Harvard Bioscience, Inc.
HBIO		 BlackRock Inc.
BLK		 2,913,814
6.800%		 1,704,695increase
(+140.99%)		 Filing
2022-07-08
4:57 pm
Sale		 2022-06-30 13G Harvard Bioscience, Inc.
HBIO		 BlackRock Inc.
BLK		 1,209,119
2.900%		 -1,854,071decrease
(-60.53%)		 Filing
2022-02-02
7:11 pm
Purchase		 2021-12-31 13G Harvard Bioscience, Inc.
HBIO		 BlackRock Inc.
BLK		 3,063,190
7.500%		 109,285increase
(+3.70%)		 Filing
2021-02-02
2:56 pm
Purchase		 2020-12-31 13G Harvard Bioscience, Inc.
HBIO		 BlackRock Inc.
BLK		 2,953,905
7.600%		 1,505,228increase
(+103.90%)		 Filing